T. Rowe Price Associates’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,830
| Closed | -$27K | – | 2966 |
|
|
2022
Q3 | $27K | Hold |
1,830
| – | – | ﹤0.01% | 2896 |
|
|
2022
Q2 | $33K | Sell |
1,830
-249
| -12% | -$4.49K | ﹤0.01% | 2895 |
|
|
2022
Q1 | $62K | Buy |
2,079
+725
| +54% | +$21.6K | ﹤0.01% | 2897 |
|
|
2021
Q4 | $59K | Sell |
1,354
-100
| -7% | -$4.36K | ﹤0.01% | 2916 |
|
|
2021
Q3 | $104K | Buy |
1,454
+10
| +0.7% | +$715 | ﹤0.01% | 2832 |
|
|
2021
Q2 | $166K | Sell |
1,444
-920
| -39% | -$106K | ﹤0.01% | 2760 |
|
|
2021
Q1 | $245K | Buy |
+2,364
| New | +$245K | ﹤0.01% | 2623 |
|